Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Detail</td><td align="center">Percentage</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Survival</td><td align="center"> </td></tr><tr><td align="left"> Overall</td><td align="center">85%</td></tr><tr><td align="left"> Disease free</td><td align="center">66.7%</td></tr><tr><td align="left"> Cancer-related death</td><td align="center">5.5%</td></tr><tr><td align="left">Recurrence</td><td align="center"> </td></tr><tr><td align="left"> Local</td><td align="center">33.3%</td></tr><tr><td align="left"> Distant</td><td align="center">66.6%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

BioMed Research International

tab3

Table 3

Table 3: Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer 